Dr Reddy's announces launch of Sildenafil tablets

Pharma major Dr Reddy's Laboratories today announced that it has launched Sildenafil tablets, a

RELATED ARTICLES

bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

This followed the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's ANDA for Sildenafil tablets, a company statement said here.

The Revatio brand had US sales of approximately $38.67 million for the most recent twelve months ending September 2012, according to IMS Health.

Dr Reddy's Sildenafil tablets in 20 mg are available in 90 count bottle sizes, the release said.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • FDI in insurance must be allowed with a rider to increase penetration

    The Union cabinet has cleared the proposal to raise foreign direct investment (FDI) in the insurance sector through the FIPB route from the current 26

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Varun Dutt

Which is safer? Flying or driving?

The recent tragedies involving the Taiwan’s TransAsia Airways flight, and ...

Parvez Imam

Revisiting history can do us all good

We often think that we understand history. We read it ...

Bubbles Sabharwal

Your happiness doesn’t depend on your needs

They are two different words (and even worlds) altogether: having ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture